Ayanian John Z, Landon Bruce E, Newhouse Joseph P, Zaslavsky Alan M
From the Institute for Healthcare Policy and Innovation, the Division of General Medicine, University of Michigan Medical School, the Department of Health Management and Policy, University of Michigan School of Public Health, and the Gerald R. Ford School of Public Policy, University of Michigan - all in Ann Arbor (J.Z.A.); the Department of Health Care Policy, Harvard Medical School (J.Z.A., B.E.L., J.P.N., A.M.Z.), the Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School (B.E.L.), and the Department of Health Policy and Management, Harvard School of Public Health (J.P.N.) - all in Boston; and the Harvard Kennedy School and the National Bureau of Economic Research - both in Cambridge, MA (J.P.N.).
N Engl J Med. 2014 Dec 11;371(24):2288-97. doi: 10.1056/NEJMsa1407273.
Differences in the control of blood pressure, cholesterol, and glucose among the various racial and ethnic groups of Medicare enrollees may contribute to persistent disparities in health outcomes.
Among elderly enrollees in Medicare Advantage health plans in 2011 who had hypertension (94,171 persons), cardiovascular disease (112,039), or diabetes (105,848), we compared the respective age-and-sex-adjusted proportions with blood pressure lower than 140/90 mm Hg, low-density lipoprotein cholesterol levels below 100 mg per deciliter (2.6 mmol per liter), and a glycated hemoglobin value of 9.0% or lower, according to race or ethnic group. Comparisons were made nationally and within regions and health plans, and changes since 2006 were assessed.
Black enrollees in 2006 and 2011 were substantially less likely than white enrollees to have adequate control of blood pressure (adjusted absolute differences in proportions of enrollees in the 2 years, 7.9 percentage points and 10.3 percentage points, respectively), cholesterol (11.4 percentage points and 10.2 percentage points, respectively), and glycated hemoglobin (10.1 percentage points and 9.4 percentage points, respectively) (P<0.001 for all comparisons). Differing distributions of enrollees among health plans accounted for 39 to 59% of observed disparities in 2011. These differences persisted in 2011 in the Northeast, Midwest, and South (6.9 to 14.1 percentage points, P<0.001 for all comparisons) but were eliminated in the West for all three measures (<1.5 percentage points, P≥0.15). Hispanic enrollees were less likely than whites in 2011 to have adequate control of blood pressure (adjusted difference, 1.6 percentage points), cholesterol (adjusted difference, 1.0 percentage points), and glycated hemoglobin (adjusted difference, 3.4 percentage points) (P≤0.02 for all comparisons). Asians and Pacific Islanders were more likely than whites to have adequate control of blood pressure (difference, 4.4 percentage points; P<0.001) and cholesterol (5.5 percentage points, P<0.001) and had similar control of glycated hemoglobin (0.3 percentage points, P=0.63).
Disparities in control of blood pressure, cholesterol, and glucose have not improved nationally for blacks in Medicare Advantage plans, but these disparities were eliminated in the West in 2011. (Funded by the National Institute on Aging.).
医疗保险参保者中不同种族和族裔群体在血压、胆固醇和血糖控制方面存在差异,这可能导致健康结果方面持续存在差距。
在2011年参加医疗保险优势健康计划的老年参保者中,患有高血压(94171人)、心血管疾病(112039人)或糖尿病(105848人)的患者,我们根据种族或族裔群体,比较了年龄和性别调整后血压低于140/90 mmHg、低密度脂蛋白胆固醇水平低于100 mg/dL(2.6 mmol/L)以及糖化血红蛋白值为9.0%或更低的各自比例。在全国范围内以及在各地区和健康计划内进行了比较,并评估了自2006年以来的变化。
2006年和2011年,黑人参保者在血压(两年参保者比例的调整后绝对差异分别为7.9个百分点和10.3个百分点)、胆固醇(分别为11.4个百分点和10.2个百分点)和糖化血红蛋白(分别为10.1个百分点和9.4个百分点)方面得到充分控制的可能性明显低于白人参保者(所有比较P<0.001)。健康计划中参保者的不同分布占2011年观察到的差距的39%至59%。这些差异在2011年在东北部、中西部和南部仍然存在(6.9至14.1个百分点,所有比较P<0.001),但在西部所有三项指标中均消除(<1.5个百分点,P≥0.15)。2011年,西班牙裔参保者在血压(调整后差异为1.6个百分点)、胆固醇(调整后差异为1.0个百分点)和糖化血红蛋白(调整后差异为3.4个百分点)方面得到充分控制的可能性低于白人(所有比较P≤0.02)。亚洲人和太平洋岛民在血压(差异为4.4个百分点;P<0.001)和胆固醇(5.5个百分点,P<0.001)方面得到充分控制的可能性高于白人,并且在糖化血红蛋白控制方面相似(0.3个百分点,P=0.63)。
在医疗保险优势计划中,黑人在血压、胆固醇和血糖控制方面的差距在全国范围内没有改善,但这些差距在2011年在西部消除了。(由美国国立衰老研究所资助。)